Item request has been placed!

Item request cannot be made.

Processing Request

Search Results

Display Settings

Results per page: 10

Sort By: Relevance

Filter

Your Filters

Format : News

Reset filters

Item request has been placed!

Item request cannot be made.

Processing Request

News

Affiliated Drum Tower Hospital of Nanjing University Medical School Researcher Updates Current Study Findings on Hepatic Encephalopathy (Efficacy of transjugular intrahepatic portosystemic shunt in treatment of primary biliary cholangitis with ...)

Source: Cardiovascular Week. March 27, 2023, 110

Record details

Read Online Read More Add to Saved list

News

New Hepatic Encephalopathy Study Findings Have Been Reported by Investigators at Johannes Gutenberg University of Mainz (Impact of Non-selective Beta-blockers On Hepatic Encephalopathy In Patients With Liver Cirrhosis)

Source: Health & Medicine Week. February 26, 2021, 4212

Record details

Read Online Read More Add to Saved list

News

Ocera Therapeutics completes first in human studies with OCR-002 for the treatment of Hyperammonemia and Hepatic Encephalopathy.

Source: Chemical Business Newsbase. 2010.

Record details

Ocera Therapeutics Completes First in Human Studies with OCR-002 for the Treatment of Hyperammonemia and Hepatic Encephalopathy.

Source: PR Newswire. 2010.

Record details

Hyperion Therapeutics Receives Orphan Drug Designation for HPN-100 for the Treatment of Hepatic Encephalopathy.

Source: Business Wire. 2009.

Record details

Hyperion Therapeutics Receives Orphan Drug Designation for HPN-100 for the Treatment of Hepatic Encephalopathy

Source: Clinical Trials Week. Sept 28, 2009, p57

Record details

Read Online Read More Add to Saved list

News

Rifaximin approved for hepatic encephalopathy

Source: Alcoholism & Drug Abuse Weekly. March 8, 2010, Vol. 22 Issue 10, p7, 1 p.

Record details

Read Online Read More Add to Saved list

menu

Search Results

Your Filters

Affiliated Drum Tower Hospital of Nanjing University Medical School Researcher Updates Current Study Findings on Hepatic Encephalopathy (Efficacy of transjugular intrahepatic portosystemic shunt in treatment of primary biliary cholangitis with ...)

New Hepatic Encephalopathy Study Findings Have Been Reported by Investigators at Johannes Gutenberg University of Mainz (Impact of Non-selective Beta-blockers On Hepatic Encephalopathy In Patients With Liver Cirrhosis)

Ocera Therapeutics completes first in human studies with OCR-002 for the treatment of Hyperammonemia and Hepatic Encephalopathy.

Ocera Therapeutics Completes First in Human Studies with OCR-002 for the Treatment of Hyperammonemia and Hepatic Encephalopathy.

Hyperion Therapeutics Receives Orphan Drug Designation for HPN-100 for the Treatment of Hepatic Encephalopathy.

Hyperion Therapeutics Receives Orphan Drug Designation for HPN-100 for the Treatment of Hepatic Encephalopathy

Rifaximin approved for hepatic encephalopathy

Contact CCPL

Patron Login

menu

Search Results

Your Filters

Affiliated Drum Tower Hospital of Nanjing University Medical School Researcher Updates Current Study Findings on Hepatic Encephalopathy (Efficacy of transjugular intrahepatic portosystemic shunt in treatment of primary biliary cholangitis with ...)

New Hepatic Encephalopathy Study Findings Have Been Reported by Investigators at Johannes Gutenberg University of Mainz (Impact of Non-selective Beta-blockers On Hepatic Encephalopathy In Patients With Liver Cirrhosis)

Ocera Therapeutics completes first in human studies with OCR-002 for the treatment of Hyperammonemia and Hepatic Encephalopathy.

Ocera Therapeutics Completes First in Human Studies with OCR-002 for the Treatment of Hyperammonemia and Hepatic Encephalopathy.

Hyperion Therapeutics Receives Orphan Drug Designation for HPN-100 for the Treatment of Hepatic Encephalopathy.

Hyperion Therapeutics Receives Orphan Drug Designation for HPN-100 for the Treatment of Hepatic Encephalopathy

Rifaximin approved for hepatic encephalopathy

Engage with CCPL

Contact CCPL